IDV vehicle

36F79722D0036

65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$2.2M
Start dateDec 15, 2021
Current end dateNot available
Potential end dateNot available
Latest award activityMay 21, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 21, 2026P00017$0COMMERCIAL CHANGE(S) PRODUCT DELETIONS
Apr 20, 2026P00016$065IB - ADMINISTRATIVE CHANGES - COMPANY ADDRESS & SIGNATORY AUTHORITY FORM CHANGES
Nov 17, 2025P00014$0ADMIN CHANGES - POC UPDATES
Nov 12, 2025P00015$02026 PUBLIC LAW PRICING UPDATES
Dec 21, 2024P00013$0SIGNATURE OF AUTHORITY UPDATE
Nov 13, 2024P00012$02025 PUBLIC LAW PRICING UPDATES
Oct 29, 2024P00011$0COMMERCIAL CHANGES TO SIGNATURE OF AUTHORITY
Aug 28, 2024P00010$065IB / CHANGE-OF-NAME AGREEMENT / ADMINISTRATIVE POC / IFF SALES POC / ORDERING CONTACT / COMPANY INFORMATION / SIGNATORY AUTHROITY (SA)
Jan 22, 2024P00009$0UPDATE POC EMAIL ADDRESS
Nov 24, 2023P00008$02024 PL
Oct 6, 2023P00007$0UPDATE IFF SALES POC
Mar 1, 2023P00006$0POC
Feb 8, 2023P00005$0LIFECYCLE CHANGE
Jan 31, 2023P00004$0DEL
Nov 23, 2022P00003$02023 PUBLIC LAW
Sep 14, 2022P00002$0ADD
May 19, 2022P00001$0IFF POC
Dec 5, 20210$065 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.